USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: NANOVA, INC.
Address: 1005 BROOK TROUT CT
COLUMBIA, MO
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $887,716.00 3
SBIR Phase II $2,889,571.00 2

Award List:

Development of a Miniature Plasma Brush for Dental Clinical Applications

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Meng Chen
Award Amount: $157,804.00
Abstract:
DESCRIPTION (provided by applicant): Nanova, Inc. is developing a miniature non-thermal gas plasma brush that is operated in open air and can be used for dental cavity treatment and preparation in dental clinics. To date, preparation of dental cavities pr ior to filling relies on mechanical… More

Calcium Phosphate Bone Cement Nanocomposites

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kenneth L. Lambert
Award Amount: $509,669.00
Abstract:
DESCRIPTION (provided by applicant): Calcium phosphate cements (CPCs) are used in orthopedic surgery as bone filler and have been proved with very good biocompatibility. However, the inadequate mechanical properties have significantly impeded their clinica l applications despite of the good… More

Development of a Miniature Plasma Brush for Dental Clinical Applications

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Meng Chen
Award Amount: $1,533,990.00
Abstract:
DESCRIPTION (provided by applicant): The main objective of this project is to develop a miniature atmospheric cold plasma brush (m- ACPB) for dental clinical applications. The innovation of this project is the utilization of the recently developed novel no n-thermal atmospheric plasma technology for… More

Improved long-term biocompatibility of coronary stents by plasma coating process

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Meng Chen – 573-234-6451
Award Amount: $220,243.00
Abstract:
DESCRIPTION (provided by applicant): Improved long-term biocompatibility of coronary stents by plasma coating process Abstract Drug-eluting stents (DES) have been widely used to treat patients of cardiac disease due to their better ability to control restenosis than bare metal stents (BMS). However,… More

Improved long-term biocompatibility of coronary stents by plasma coating process

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Meng Chen – 573-234-6451
Award Amount: $1,355,581.00
Abstract:
DESCRIPTION (provided by applicant): Improved long-term biocompatibility of coronary stents by plasma coating process Abstract Drug-eluting stents (DES) have been widely used to treat patients of cardiac disease due to their better ability to control restenosis than bare metal stents (BMS). However,… More